GSK officer plans sale of 44,397 ADS in 2026

GSK plc (GSK) has a notice of proposed sale under Rule 144 filed for the account of officer Maria E Martinez.

Rhea-AI Filing Summary

GSK plc (GSK) has a notice of proposed sale under Rule 144 filed for the account of officer Maria E Martinez. The notice covers up to 44,397 American Depositary Shares of GSK to be sold through Charles Schwab & Co. on or after 08/20/2026 on the NYSE. The shares were acquired in multiple transactions, including Share Value Plan vesting on 02/19/2025 and 02/09/2026, Performance Share Plan vesting on 02/13/2026, and several dividend reinvestments in 2025–2026.

Key Figures

ADS proposed for sale: 44,397 American Depositary Shares Aggregate market value: $2,312,106.96 Earliest sale date: 08/20/2026 +2 more

5 metrics

ADS proposed for sale 44,397 American Depositary Shares Maximum number of GSK ADS covered by Rule 144 notice

Aggregate market value $2,312,106.96 Aggregate market value of 44,397 ADS in Rule 144 notice

Earliest sale date 08/20/2026 Date from which the 44,397 ADS may be sold

Share Value Plan vesting 6,665 American Depositary Shares Shares acquired via Share Value Plan vesting on 02/19/2025

Performance Share Plan vesting 33,827 American Depositary Shares Shares acquired via Performance Share Plan vesting on 02/13/2026

Key Terms

Rule 144, AMERICAN DEPOSITARY SHARES, Share Value Plan Vesting, Performance Share Plan Vesting

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

AMERICAN DEPOSITARY SHARES financial

"AMERICAN DEPOSITARY SHARES | CHARLES SCHWAB & CO"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Share Value Plan Vesting financial

"02/19/2025 | Share Value Plan Vesting | Issuer"

Performance Share Plan Vesting financial

"02/13/2026 | Performance Share Plan Vesting | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for GSK (GSK)?

The Form 144 discloses that officer Maria E Martinez intends to sell up to 44,397 GSK American Depositary Shares under Rule 144. These shares are planned to be sold through Charles Schwab & Co. on or after 08/20/2026 on the NYSE.

How many GSK (GSK) shares are covered by Maria E Martinez’s planned Rule 144 sale?

The notice covers up to 44,397 American Depositary Shares of GSK. This amount is listed with an aggregate market value of $2,312,106.96 for the proposed Rule 144 sale through Charles Schwab & Co.

When can the GSK (GSK) shares under this Form 144 be sold?

The shares may be sold on or after 08/20/2026. The filing lists this date alongside the 44,397 American Depositary Shares proposed for sale, indicating the earliest sale date under the Rule 144 notice.

How were the GSK (GSK) shares in this Form 144 acquired by Maria E Martinez?

The shares were acquired via Share Value Plan vesting, Performance Share Plan vesting, and Dividend Reinvestment. Specific events include 6,665 ADS from Share Value Plan vesting on 02/19/2025 and 33,827 ADS from Performance Share Plan vesting on 02/13/2026.

What is the reported market value of the GSK (GSK) shares in the planned Rule 144 sale?

The filing reports an aggregate market value of $2,312,106.96 for the 44,397 American Depositary Shares. This figure is tied to the proposed Rule 144 sale of GSK ADS through Charles Schwab & Co.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 11:19 AM Accepted by SEC EDGAR 08/20/2026 - 11:19 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001761768
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GSK plc
SEC File Number	001-15170
Address of Issuer	79 NEW OXFORD STREET LONDON UNITED KINGDOM WC1A 1DG
Phone	44 20 8047 5000
Name of Person for Whose Account the Securities are To Be Sold	Martinez Maria E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
AMERICAN DEPOSITARY SHARES	CHARLES SCHWAB & CO 3000 SCHWAB WAY WESTLAKE TX 76262	44397	2312106.96	4315445026	08/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
AMERICAN DEPOSITARY SHARES	02/19/2025	Share Value Plan Vesting	Issuer			6665	02/19/2025	N/A
AMERICAN DEPOSITARY SHARES	04/15/2025	DIVIDEND REINVESTMENT	n/a			57	04/15/2025	n/a
AMERICAN DEPOSITARY SHARES	07/17/2025	Dividend Reinvestment	n/a			58	07/17/2025	n/a
AMERICAN DEPOSITARY SHARES	10/14/2025	Dividend Reinvestment	n/a			50	10/14/2025	n/a
AMERICAN DEPOSITARY SHARES	01/14/2026	Dividend Reinvestment	n/a			44	01/14/2026	n/a
AMERICAN DEPOSITARY SHARES	02/09/2026	Share Value Plan Vesting	Issuer			7869	02/09/2026	n/a
AMERICAN DEPOSITARY SHARES	02/13/2026	Performance Share Plan Vesting	Issuer			33827	02/13/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maria E Martinez
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)